CSI Market
Sign In | Register

Takeda Pharmaceutical Limited (TAK) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access TAK Annual Balance Sheets →
From Takeda Pharmaceutical Limited through 0, shifts in Jun 30 2026's assets and liabilities provide insight into the company's capital structure and financial stability.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Mar 31 2025) 0 0 0
Assets
Cash And Cash Equivalents0.00
Current Tax Assets Current0.00
Cash & Short-term Investments0.00
Accounts receivable0.00
Trade & Other Current Receivables (IFRS combined total)-
Notes Receivable, Current0.00
Inventories0.00
Other Current Assets0.00
Total Current Assets0.00
Goodwill net0.00
Intangible Assets0.00
Deferred Tax Assets0.00
Other Assets, Noncurrent96,732.83
Total Assets96,732.83
Liabilities
Accounts Payable0.00
Longterm Borrowings0.00
Current Provisions0.00
Total Current Liabilities0.00
Long-term debt0.00
Total Long-term Debt0.00
Deferred Tax Liabilities, Net LI0.00
Noncurrent Provisions50,050.91
Total Liabilities50,050.91
Stockholders' Equity
Other Equity0.00
Common Stockholder's Equity46,681.91
Total Stockholder's Equity46,681.91
Liabilities & Stockholder's Equity96,732.83
4 historic quarters locked

Sign in to unlock the full Takeda Pharmaceutical Limited balance sheet history.

Sign In Create Free Account

About Takeda Pharmaceutical Co Ltd Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 20-F (Period: 20260331)
  • Filed with the SEC: June 17, 2026
  • Source: tak-20260331.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001395064-26-000177

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI